Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,460
-70 (-0.48%)
Feb 21, 2025, 9:00 AM KST

Daewon Pharmaceutical Market Cap

Daewon Pharmaceutical has a market cap or net worth of 309.93 billion as of February 21, 2025. Its market cap has decreased by -2.06% in one year.

Market Cap
309.93B
Enterprise Value
438.56B
Revenue
593.94B
Ranking
n/a
PE Ratio
19.12
Stock Price
14,460.00

Market Cap Chart

Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 309.93B, an increase of 1,616.11%. That is a compound annual growth rate of 12.58%.

History

DateMarket Cap% Change
Feb 21, 2025309.93B1.47%
Dec 30, 2024305.43B-7.98%
Dec 28, 2023331.93B-15.58%
Dec 29, 2022393.20B14.64%
Dec 30, 2021343.00B-9.91%
Dec 30, 2020380.71B13.65%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 82.28T
Celltrion 38.31T
SK Biopharmaceuticals 9,327.11B
Yuhan 9,276.18B
SK bioscience 3,729.33B
Hanmi Pharm. 3,328.56B
Hanall Biopharma 1,995.45B
Hanmi Science 1,946.77B
Market Cap Rankings